Ezaldein Harib Hassan – Trademark Portfolio
Entity Type: 01
Ezaldein Harib Hassan holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 4 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include SKINGINEER and SKINGINEERING. The owner is based in Cleveland, OH.
2222 Detroit Ave, suite 1115,
Cleveland, OH 44113
Showing of trademarks Trademarks
Trademark Classifications
Ezaldein Harib Hassan's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Ezaldein Harib Hassan have?
Ezaldein Harib Hassan has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 abandoned.
What trademark classes does Ezaldein Harib Hassan file in?
Ezaldein Harib Hassan files trademarks across 3 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are Ezaldein Harib Hassan's most well-known trademarks?
Ezaldein Harib Hassan's registered trademark portfolio includes well-known marks such as SKINGINEER and SKINGINEERING. These are among 2 currently registered trademarks in the portfolio.
What is Ezaldein Harib Hassan's trademark registration success rate?
Ezaldein Harib Hassan has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.